Specifically, KM curve analyses show that the MTP-BCR method identifies ~17% more high-risk women (in the 90th percentile and above) likely to be diagnosed with breast cancer within 10 years compared to other methods, enabling more aggressive screening and prevention strategies44. The gene discussed is BCR; the disease is breast carcinoma.